Literature DB >> 12869493

BCL-3 overexpression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

George Z Rassidakis, Mauricio P Oyarzo, L Jeffrey Medeiros.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12869493     DOI： 10.1182/blood-2003-04-1366

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

Review 1.  Reappraisal of BCL3 as a molecular marker of anaplastic large cell lymphoma.

Authors:  Hitoshi Ohno; Momoko Nishikori; Yoshitomo Maesako; Hironori Haga
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

2.  The tumor promoter and NF-κB modulator Bcl-3 regulates splenic B cell development.

Authors:  Xiaoren Zhang; Andrea Paun; Estefania Claudio; Hongshan Wang; Ulrich Siebenlist
Journal:  J Immunol       Date:  2013-11-15       Impact factor: 5.422

Review 3.  NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.

Authors:  Paula Grondona; Philip Bucher; Klaus Schulze-Osthoff; Stephan Hailfinger; Anja Schmitt
Journal:  Biomedicines       Date:  2018-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.